Limelight Bio

Limelight Bio, Inc. is an emerging biotech company developing novel gene therapies that greatly expand the utility of clinically-validated AAV vectors to enable the treatment of debilitating inherited diseases that cannot be addressed by current technologies; such as those caused by mutations in large genes and autosomal dominant inheritance patterns. Limelight was founded by experienced scientific leaders from the University of Pennsylvania and backed by Apple Tree Partners, a leading life science venture capital firm.

Share